The Disorder of Circadian Clock Gene and Early Cognitive Dysfunction After General Anesthesia

Sponsor
Shengjing Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04421872
Collaborator
(none)
1,000
1
2
42
23.8

Study Details

Study Description

Brief Summary

Postoperative cognitive dysfunction (POCD) is a common postoperative complication in patients aged 65 and over, which refers to cognitive function changes such as memory decline and attention deficit after anesthesia and surgery. In severe cases, personality changes and social behavior decline may also occur, resulting in irreversible cognitive impairment.Previous studies have suggested that cognitive dysfunction after general anesthesia is linked to a genetic disorder of the body clock.Exosomes are cellular forms of cellular microvesicles containing complex RNA and proteins.Exosomes can mediate the expression of genes in the late transcriptional period of the clock system, and directly or indirectly participate in the negative regulation of rhythm expression of minute control genes, playing an important role in the intercellular circadian rhythm information output pathway.Rhythm disorders in the core biological clock system of urinary exosomes and the clock control genes related to kidney can early indicate circadian rhythm changes in the core biological clock system.The sorting and detection of urinary exosome clock information materials in patients has the advantages of easy access, continuous monitoring, early diagnosis and less damage, making urinary exosome a biomarker for the diagnosis and monitoring of circadian rhythm of a good kidney biological clock system.

Condition or Disease Intervention/Treatment Phase
  • Other: receiving general anesthesia
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
The Relationship Between the Disorder of Circadian Clock Gene and Early Cognitive Dysfunction After General Anesthesia
Anticipated Study Start Date :
Jul 1, 2020
Anticipated Primary Completion Date :
Jul 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: General anesthesia Group

Other: receiving general anesthesia
patients receiving surgery under general anesthesia

No Intervention: Healthy control group

Outcome Measures

Primary Outcome Measures

  1. Neurocognitive testing [one day before the surgery]

    Neurocognitive testing was performed preoperatively and 6 weeks postoperatively, followed up 1 and 3 years postoperatively.

  2. Neurocognitive testing [6 weeks after surgery]

    Neurocognitive testing was performed preoperatively and 6 weeks postoperatively, followed up 1 and 3 years postoperatively.

  3. Neurocognitive testing [1 year after surgery]

    Neurocognitive testing was performed preoperatively and 6 weeks postoperatively, followed up 1 and 3 years postoperatively.

  4. Neurocognitive testing [3 years after surgery]

    Neurocognitive testing was performed preoperatively and 6 weeks postoperatively, followed up 1 and 3 years postoperatively.

  5. Core clock gene and kidney clock control gene detection [at the end of surgery]

    The urine exosomes were extracted by overspeed centrifugation method. The mRNA ( messenger ribonucleic acid) expression results of the core heart clock gene and the renal bell control genes in the urinary exosomes were detected by timing and quantitative PCR(Polymerase Chain Reaction) and the rhythm was analyzed

  6. Blood samples and Apolipoprotein E genotyping [at the end of surgery]

    peripheral blood was collected from each patient for apolipoprotein E genotyping.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients whose age ≥ 18 years old and <90 years of preoperative sleep disorder;

  • Primary cancer patients who had not received any radiotherapy or chemotherapy before surgery;

  • Surgeries expected to be performed under general anesthesia after ≧3 hours

Exclusion Criteria:
  • a history of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis;

  • inability to communicate due to coma, severe dementia, language impairment or serious illness;

  • critically ill (preoperative ASA (American Society of Anesthesiologists)>III), Childe-Pugh C or severe renal insufficiency (preoperative dialysis);

  • Neurosurgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Junchao Zhu Shenyang China 110004

Sponsors and Collaborators

  • Shengjing Hospital

Investigators

  • Principal Investigator: Junchao Zhu, Shengjing Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yanchao Yang, Principal investigator, Shengjing Hospital
ClinicalTrials.gov Identifier:
NCT04421872
Other Study ID Numbers:
  • general anesthesia and POCD
First Posted:
Jun 9, 2020
Last Update Posted:
Jun 9, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yanchao Yang, Principal investigator, Shengjing Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2020